Cannabis & Cannabinoids at 39th ECNP Congress
1 session on cannabis & cannabinoids · October 10–13, 2026, Munich, Germany. Compare cannabis & cannabinoids at other meetings →
Monday, October 12
Symposium
S15 – Novel Therapies Symposium – showcasing clinical trials on emerging compounds and new medical devices
Lone Baandrup · Viktoria Damgaard · Daniel Umbricht · Susan L. Rossell · Alexandra Philipsen · Mikołaj Matłoka
Trial results on emerging treatments including cannabidiol vs risperidone for cannabis-related psychosis (CANRISE), a novel oral NMDA antagonist, PDE10A inhibition in schizophrenia, and digital devices.
Other topics at this meeting
Neuroscience & Mechanisms 23Drug Pipeline & Clinical Trials 8Digital Psychiatry & AI 7Pharmacogenomics & Precision Psychiatry 7Inflammation & Immunopsychiatry 6Schizophrenia & Psychosis 6Child & Adolescent 5Depression 5Autism & Neurodevelopmental Disorders 4Neuromodulation (ECT, TMS) 4OCD & Related Disorders 4ADHD 3